Investor Materials
Annual Report
View an enhanced version of our Annual Report.
Proxy Statement
View an enhanced version of our Proxy Statement.
The secure way to view our annual documents and vote your shares.
View an enhanced version of our Annual Report.
View an enhanced version of our Proxy Statement.
YOUR VOTE IS IMPORTANT!
Please be sure to vote your proxy today. You may vote online or by phone by dialing 866-362-4346.
*Note: You must register by the deadline to be eligible to participate in the meeting.
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in complement, we ushered in the first new class of complement medicine in 15 years with the approval of the first and only targeted C3 therapy. We are advancing this science to continually develop transformative medicines for people living with rare, retinal, and neurological diseases.
